The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 80,224 | 76,192 | 71,424 | 64,977 | 60,921 |
| Cost of Goods | 65,107 | 62,093 | 55,795 | 51,977 | 49,779 |
| Gross Profit | 15,117 | 14,099 | 15,629 | 13,000 | 11,142 |
| Operating Expenses | 30,162 | 47,059 | 41,503 | 34,074 | 30,225 |
| Operating Income | -14,938 | -32,867 | -25,079 | -20,097 | -18,304 |
| Interest Expense | 1,638 | 1,443 | 2,450 | 1,497 | 61 |
| Other Income | -222 | 4,356 | 16,155 | 18,896 | 12,880 |
| Pre-tax Income | -16,798 | -29,954 | -11,374 | -2,698 | -5,485 |
| Income Tax | 99 | 44 | -367 | -24 | -32 |
| Net Income Continuous | -16,897 | -29,998 | -11,007 | -2,674 | -5,453 |
| Net Income | $-16,897 | $-29,998 | $-11,007 | $-2,674 | $-5,453 |
| EPS Basic Total Ops | -0.19 | -0.33 | -0.13 | -0.03 | -0.06 |
| EPS Basic Continuous Ops | -0.23 | -0.41 | -0.15 | -0.04 | -0.07 |
| EPS Diluted Total Ops | -0.19 | -0.33 | -0.19 | -0.17 | -0.06 |
| EPS Diluted Continuous Ops | -0.23 | -0.41 | -0.14 | -0.03 | -0.07 |
| EBITDA(a) | $-12,734 | $-14,128 | $-13,382 | $-18,100 | $-17,206 |